National burden of achondroplasia: an analysis of the National Inpatient and Nationwide Ambulatory Surgery Samples
Publication: Journal of Comparative Effectiveness Research
Abstract
Background: To estimate the cost of US hospital admissions and outpatient surgeries associated with achondroplasia. Materials & methods: Using 2017 data from nationally representative databases, this study identifies hospital admissions and outpatient encounters with an achondroplasia diagnosis. Descriptive measures are reported. Results: There were 1985 achondroplasia admissions nationwide. The most frequent admissions were neonatal care (33.7%) in children and musculoskeletal (22.7%) in adults. Average hospital length of stay was 6.8 days, 2.2 days longer than the US mean. Total mean inpatient costs were US$19,959, $7789 greater than the US mean. In the outpatient setting, children 5–14 years accounted for 56.9% of procedures. Conclusion: Achondroplasia is a serious condition with a wide range of lifelong complications frequently requiring hospitalization and surgical intervention.
Formats available
You can view the full content in the following formats:
References
Papers of special note have been highlighted as: • of interest; •• of considerable interest
1.
Foreman PK, Kessel F, Hoorn R, Bosch J, Shediac R, Landis S. Birth prevalence of achondroplasia: a systematic literature review and meta‐analysis. Am. J. Med. Genet. A. 182(10), 2297–2316 (2020).
2.
Pauli RM. Achondroplasia: a comprehensive clinical review. Orphanet J. Rare Dis. 14(1), 1 (2019).
• This review provides a background on the healthcare needs of patients with achondroplasia, current management options for the disease including areas of controversy and the gaps in knowledge and available therapies.
3.
Shirley ED, Ain MC. Achondroplasia: manifestations and treatment. J. Am. Acad. Orthop. Surg. 17(4), 231–241 (2009).
4.
Okenfuss E, Moghaddam B, Avins AL. Natural history of achondroplasia: a retrospective review of longitudinal clinical data. Am. J. Med. Genet. A. 182(11), 2540–2551 (2020).
•• This analysis of electronic health records finds that achondroplasia has a significant lifetime impact on patients’ physical health, including the need for intervention beyond childhood.
5.
Horton WA, Hall JG, Hecht JT. Achondroplasia. Lancet 370(9582), 162–172 (2007).
6.
Kubota T, Adachi M, Kitaoka T et al. Clinical practice guidelines for achondroplasia*. Clin. Pediatr. Endocrinol. 29(1), 25–42 (2020).
7.
Unger S, Bonafé L, Gouze E. Current care and investigational therapies in achondroplasia. Curr. Osteoporos. Rep. 15(2), 53–60 (2017).
8.
Högler W, Ward LM. New developments in the management of achondroplasia. Wien. Med. Wochenschr. 1946 170(5–6), 104–111 (2020).
9.
Wright MJ, Irving MD. Clinical management of achondroplasia. Arch. Dis. Child. 97(2), 129–134 (2012).
10.
Ireland P, Pacey V, Zankl A, Edwards P, Johnson L, Savarirayan R. Optimal management of complications associated with achondroplasia. Appl. Clin. Genet. 7, 117 (2014).
11.
Afsharpaiman S, Saburi A, Waters KA. Respiratory difficulties and breathing disorders in achondroplasia. Paediatr. Respir. Rev. 14(4), 250–255 (2013).
12.
Hunter AG, Bankier A, Rogers JG, Sillence D, Scott CI. Medical complications of achondroplasia: a multicentre patient review. J. Med. Genet. 35(9), 705–712 (1998).
13.
Tunkel D, Alade Y, Kerbavaz R, Smith B, Rose-Hardison D, Hoover-Fong J. Hearing loss in skeletal dysplasia patients. Am. J. Med. Genet. A. 158A(7), 1551–1555 (2012).
14.
Alade Y, Tunkel D, Schulze K et al. Cross-sectional assessment of pain and physical function in skeletal dysplasia patients: cross-sectional assessment of pain and physical function in SD patients. Clin. Genet. 84(3), 237–243 (2013).
15.
Dhiman N, Albaghdadi A, Zogg CK et al. Factors associated with health-related quality of life (HRQOL) in adults with short stature skeletal dysplasias. Qual. Life Res. 26(5), 1337–1348 (2017).
16.
Jeong S-T, Song H-R, Keny SM, Telang SS, Suh S-W, Hong S-J. MRI study of the lumbar spine in achondroplasia: a morphometric analysis for the evaluation of stenosis of the canal. J. Bone Joint Surg. Br. 88-B(9), 1192–1196 (2006).
17.
Fredwall SO, Maanum G, Johansen H, Snekkevik H, Savarirayan R, Lidal IB. Current knowledge of medical complications in adults with achondroplasia: a scoping review. Clin. Genet. 97(1), 179–197 (2020).
• This article provides an overview of the medical complications, health characteristics and psychosocial issues in adults with achrondroplasia, as well as highlighting areas for additional research in this population.
18.
King JAJ, Vachhrajani S, Drake JM, Rutka JT. Neurosurgical implications of achondroplasia: a review. J. Neurosurg. Pediatr. 4(4), 297–306 (2009).
19.
Malcolm TL, Phan DL, Schwarzkopf R. Concomitant achondroplasia and developmental dysplasia of the hip. Arthroplasty Today 1(4), 111–115 (2015).
20.
White KK, Bober MB, Goldberg MJ et al. Best practice guidelines for management of spinal disorders in skeletal dysplasia. Orphanet J. Rare Dis. 15(1), 161 (2020).
21.
Sukhavasi A, O'Malley TJ, Maynes EJ et al. Cardiac interventions in patients with achondroplasia: a systematic review. J. Thorac. Dis. 12(3), 998–1006 (2020).
22.
Mikhael H, Vadivelu N, Braveman F. Safety of spinal anesthesia in a patient with achondroplasia for cesarean section. Curr. Drug Saf. 6(2), 130–131 (2011).
23.
Mayhew JF, Katz J, Miner M, Leiman B, Hall ID. Anaesthesia for the achondroplastic dwarf. Can. Anaesth. Soc. J. 33(2), 216–221 (1986).
24.
US FDA. FDA approves first drug to improve growth in children with most common form of dwarfism (2021). www.fda.gov/news-events/press-announcements/fda-approves-first-drug-improve-growth-children-most-common-form-dwarfism
25.
Ain MC, Abdullah MA, Ting BL et al. Progression of low back and lower extremity pain in a cohort of patients with achondroplasia. J. Neurosurg. Spine 13(3), 335–340 (2010).
26.
Nadel JL, Wilkinson DA, Garton HJL, Muraszko KM, Maher CO. Screening and surgery for foramen magnum stenosis in children with achondroplasia: a large, national database analysis. J. Neurosurg. Pediatr. 23(3), 374–380 (2019).
27.
Hoover-Fong JE, Alade AY, Hashmi SS et al. Achondroplasia natural history study (CLARITY): a multicenter retrospective cohort study of achondroplasia in the United States. Genet. Med. 23(8), 1498–1505 (2021).
•• This paper reports on the largest multicenter natural history study of achondroplasia, following a cohort established at four specialized centers over multiple decades. Rates of surgical intervention reported were consistent with our findings from a nationally representative sample.
28.
Healthcare Cost and Utilization Project (HCUP). HCUP NIS overview. Agency for Healthcare Research and Quality (2021). www.hcup-us.ahrq.gov/nisoverview.jsp
29.
Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP). Introduction to the HCUP National Inpatient Sample (NIS) 2017. Agency for Healthcare Research and Quality, MD, USA (2019).
30.
Houchens R, Ross D, Elixhauser A. Using the HCUP National Inpatient Sample to Estimate Trends. 2015. HCUP Methods Series Report # 2006-05 ONLINE. January 4, 2016. U.S. Agency for Healthcare Research and Quality. Available: www.hcup-us.ahrq.gov/reports/methods/methods.jsp
31.
Healthcare Cost and Utilization Project (HCUP). Producing national HCUP estimates (2018). www.hcup-us.ahrq.gov/tech_assist/nationalestimates/508_course/508course_2018.jsp#weighting
32.
Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP). Introduction to the HCUP National Ambulatory Surgery Sample (NASS) 2017. Agency for Healthcare Research and Quality, MD, USA (2020).
33.
Healthcare Cost and Utilization Project (HCUP). Cost-to-charge ratio files (2020). www.hcup-us.ahrq.gov/db/state/costtocharge.jsp
34.
Centers for Medicare and Medicaid Services. Design and development of the diagnosis related group (DRGs). In: ICD-10-CM/PCS MS-DRG v37.0 Defintions Manual. US Centers for Medicare and Medicaid Services, MD, USA (2019).
35.
Agency for Healthcare Research and Quality. Overview of the Nationwide Ambulatory Sample (NASS) (2020). www.hcup-us.ahrq.gov/nassoverview.jsp
36.
Best MJ, Aziz KT, McFarland EG, Anderson GF, Srikumaran U. Economic implications of decreased elective orthopaedic and musculoskeletal surgery volume during the coronavirus disease 2019 pandemic. Int. Orthop. 44, 221–2228 (2020).
37.
US Centers for Medicare andMedicaid Services. Hospital outpatient PPS (2020). www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalOutpatientPPS
38.
Agency for Healthcare Research and Quality. Free health care statistics (2020). https://hcupnet.ahrq.gov/#setup
39.
Simmons K, Hashmi SS, Scheuerle A, Canfield M, Hecht JT. Mortality in babies with achondroplasia: revisited. Infant mortality in achondroplasia. Birt. Defects Res. A. Clin. Mol. Teratol. 100(4), 247–249 (2014).
40.
On behalf of the Skeletal Dysplasia Management Consortium, Savarirayan R, Tunkel DE, Sterni LM et al. Best practice guidelines in managing the craniofacial aspects of skeletal dysplasia. Orphanet J. Rare Dis. 16(1), 31 (2021).
• This article offers best practice guidelines developed by a panel of experts using the RAND/University of California at Los Angeles modified Delphi method.
41.
Yonko EA, Emanuel JS, Carter EM, Raggio CL. Quality of life in adults with achondroplasia in the United States. Am. J. Med. Genet. A. 185(3), 695–701 (2021).
42.
Kashanian A, Chan J, Mukherjee D, Pressman BD, Krakow D, Danielpour M. Improvement in ventriculomegaly following cervicomedullary decompressive surgery in children with achondroplasia and foramen magnum stenosis. Am. J. Med. Genet. A. 182(8), 1896–1905 (2020).
43.
Booth KL, Levy DA, White DR, Meier JD, Pecha PP. Management of obstructive sleep apnea in children with achondroplasia: outcomes of surgical interventions. Int. J. Pediatr. Otorhinolaryngol. 138, 110332 (2020).
44.
Susarla SM, Mundinger GS, Kapadia H et al. Subcranial and orthognathic surgery for obstructive sleep apnea in achondroplasia. J. Craniomaxillofac. Surg. 45(12), 2028–2034 (2017).
45.
Okenfuss E, Avins A, Moghaddam B. Natural history of achondroplasia: a retrospective study of patients managed by a multispecialty program. This was a presentation at the CHMH Annual Clinical Genetics Meeting, Seattle, WA, USA (2-6 April 2019).
46.
United States Census Bureau. America’s Families and Living Arrangements: 2017 (2021). www.census.gov/data/tables/2017/demo/families/cps-2017.html
47.
Waller DK, Correa A, Vo TM et al. The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US. Am. J. Med. Genet. A. 146A(18), 2385–2389 (2008).
• This article provides an estimate of achondroplasia prevalence in the USA. We used this information to derive the hospitalization rate among children with achondroplasia and assessed this rate in the context of hospitalization rate observed in the general US population.
48.
Freed M, Fuglesten Biniek J, Damico A, Neuman T. Medicare advantage in 2021: enrollment update and key trends (2021). www.kff.org/ba73771/
49.
Bober MB, Bellus GA, Nikkel SM, Tiller GE. Hypochondroplasia. In: GeneRreviews® [Internet]. David B Everman, Ghayda M Mirzaa, Roberta A Pagon, Stephanie E Wallace (Eds). Molecular Genetics: Lora JH Bean and Karen W Gripp. Anne Amemiya, Genetic Counseling University of Washington, WA, USA (2020).
50.
Orphanet. Prevalence and incidence of rare diseases: bibliographic data (2021). www.orpha.net/consor/cgi-bin/Education_Home.php?lng=EN
51.
Buttorff C, Ruder T, Bauman M. Multiple Chronic Conditions in the United States. RAND Corporation, CA, USA (2017).
Information & Authors
Information
Published In
Pages: 1135 - 1146
PubMed: 36039778
Copyright
© 2022 The Authors. This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License
History
Received: 14 October 2021
Accepted: 28 July 2022
Published online: 30 August 2022
Keywords:
Topics
Authors
Metrics & Citations
Metrics
Article Usage
Article usage data only available from February 2023. Historical article usage data, showing the number of article downloads, is available upon request.
Citations
How to Cite
National burden of achondroplasia: an analysis of the National Inpatient and Nationwide Ambulatory Surgery Samples. (2022) Journal of Comparative Effectiveness Research. DOI: 10.2217/cer-2021-0250
Export citation
Select the citation format you wish to export for this article or chapter.
Citing Literature
- Chengaxin Duan, Yang Liu, Xuefan Gu, Dandan Ai, Jiayin Zheng, Kun Zhao, Binyan Sui, Economic Burden and Health-Related Quality of Life Among Children With Achondroplasia in China: A Cross-Sectional Study, Value in Health Regional Issues, 10.1016/j.vhri.2025.101584, (101584), (2026).
- Pranav Abraham, Gandarvaka Miles, Natalia Petruski-Ivleva, Kalyani Hawaldar, Cemre Robinson, Kenneth I. Berger, Clinical burden and healthcare resource utilization associated with achondroplasia: a real-world observational, retrospective cohort study, Orphanet Journal of Rare Diseases, 10.1186/s13023-025-04072-w, 20, 1, (2025).
- Renuka Chintapalli, Atman Desai, Achondroplasia Status and Adverse Short-Term Postoperative Outcomes in Elective Spinal Decompression Surgery: A Propensity Score-Matched Case-Control Study, Journal of Clinical Neuroscience, 10.1016/j.jocn.2025.111064, 134, (111064), (2025).
- Nadia Merchant, Jose Alvir, Paulette Negron Ericksen, Jane Loftus, Jose Francisco Cara, Alison Slade, Michael P. Wajnrajch, Christine L. Baker, Clinical and economic burden of achondroplasia in the United States: results from a retrospective, observational study, Orphanet Journal of Rare Diseases, 10.1186/s13023-024-03268-w, 20, 1, (2025).
- Moira S. Cheung, Inês Alves, Patricia Carl-Innig, Deborah Eastwood, Mohamad Maghnie, Amaka Offiah, Dror Paley, Simone Riganti, Ravi Savarirayan, Marco Sessa, Bjoern Vogt, Klaus Mohnike, Meeting report from the 3rd ISCBH-ERN BOND Achondroplasia Workshop on Long Bone Pathology in Children with Achondroplasia, Salzburg, Austria 22nd June 2024, Bone, 10.1016/j.bone.2024.117268, 190, (117268), (2025).